Concepedia

Publication | Open Access

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

DOIFull Paper Access

53

Citations

29

References

2021

Year

Eric J. Chow, Richard Aplenc, Lynda M. Vrooman, David R. Doody, Yuan‐Shung Huang, Sanjeev Aggarwal, Saro H. Armenian, K. Scott Baker, Smita Bhatia, Louis S. Constine,
Cancer

Abstract

Dexrazoxane did not appear to adversely affect long-term mortality, event-free survival, or second cancer risk.

References

YearCitations

Page 1